Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)

Alaa Rahhal; Tahseen Hamamyh; Ammar Chapra; Khaled J. Zaza; Mostafa Najim; Mohammad Hemadneh; Hazem Faraj; Wael Kanjo; Ahmed Yasin; Haneen Toba; Wafa Mohammed; Mohammad Khair Hamad; Nawras Al-Tikrety; Mhd Baraa Habib; Ahmed Awaisu; Ahmed Mahfouz; Sumaya Alyafei; Abdul Rahman Arabi; Ashfaq Patel; Mohammed Al-Hijji

doi:10.3389/fcvm.2025.1580343

Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)

Alaa Rahhal
, Tahseen Hamamyh
, Ammar Chapra
, Khaled J. Zaza
, Mostafa Najim
, Mohammad Hemadneh
, Hazem Faraj
, Wael Kanjo
, Ahmed Yasin
, Haneen Toba
, Wafa Mohammed
, Mohammad Khair Hamad
, Nawras Al-Tikrety
, Mhd Baraa Habib
, Ahmed Awaisu
, Ahmed Mahfouz
, Sumaya Alyafei
, Abdul Rahman Arabi
, Ashfaq Patel
, Mohammed Al-Hijji

Department of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the published article, there was an error in the Funding statement. The authors declared receiving no financial support for the research, authorship, or publication of this article. The correct Funding statement appears below.

Original language	English (US)
Article number	1580343
Journal	Frontiers in Cardiovascular Medicine
Volume	12
DOIs	https://doi.org/10.3389/fcvm.2025.1580343
State	Published - 2025

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine

Access to Document

10.3389/fcvm.2025.1580343

Fingerprint

Dive into the research topics of 'Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)'. Together they form a unique fingerprint.

Cite this

Rahhal, A., Hamamyh, T., Chapra, A., Zaza, K. J., Najim, M., Hemadneh, M., Faraj, H., Kanjo, W., Yasin, A., Toba, H., Mohammed, W., Hamad, M. K., Al-Tikrety, N., Baraa Habib, M., Awaisu, A., Mahfouz, A., Alyafei, S., Arabi, A. R., Patel, A., & Al-Hijji, M. (2025). Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669). Frontiers in Cardiovascular Medicine, 12, Article 1580343. https://doi.org/10.3389/fcvm.2025.1580343

@article{84f5b73c72b64c37b0e43478d7ec3538,

title = "Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)",

abstract = "In the published article, there was an error in the Funding statement. The authors declared receiving no financial support for the research, authorship, or publication of this article. The correct Funding statement appears below.",

author = "Alaa Rahhal and Tahseen Hamamyh and Ammar Chapra and Zaza, \{Khaled J.\} and Mostafa Najim and Mohammad Hemadneh and Hazem Faraj and Wael Kanjo and Ahmed Yasin and Haneen Toba and Wafa Mohammed and Hamad, \{Mohammad Khair\} and Nawras Al-Tikrety and \{Baraa Habib\}, Mhd and Ahmed Awaisu and Ahmed Mahfouz and Sumaya Alyafei and Arabi, \{Abdul Rahman\} and Ashfaq Patel and Mohammed Al-Hijji",

note = "Publisher Copyright: 2025 Rahhal, Hamamyh, Chapra, Zaza, Najim, Hemadneh, Faraj, Kanjo, Yasin, Toba, Mohammed, Hamad, Al-Tikrety, Baraa Habib, Awaisu, Mahfouz, Alyafei, Arabi, Patel and Al-Hijji.",

year = "2025",

doi = "10.3389/fcvm.2025.1580343",

language = "English (US)",

volume = "12",

journal = "Frontiers in Cardiovascular Medicine",

issn = "2297-055X",

publisher = "Frontiers Media SA",

}

Rahhal, A, Hamamyh, T, Chapra, A, Zaza, KJ, Najim, M, Hemadneh, M, Faraj, H, Kanjo, W, Yasin, A, Toba, H, Mohammed, W, Hamad, MK, Al-Tikrety, N, Baraa Habib, M, Awaisu, A, Mahfouz, A, Alyafei, S, Arabi, AR, Patel, A & Al-Hijji, M 2025, 'Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)', Frontiers in Cardiovascular Medicine, vol. 12, 1580343. https://doi.org/10.3389/fcvm.2025.1580343

Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669). / Rahhal, Alaa; Hamamyh, Tahseen; Chapra, Ammar et al.
In: Frontiers in Cardiovascular Medicine, Vol. 12, 1580343, 2025.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum

T2 - Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)

AU - Rahhal, Alaa

AU - Hamamyh, Tahseen

AU - Chapra, Ammar

AU - Zaza, Khaled J.

AU - Najim, Mostafa

AU - Hemadneh, Mohammad

AU - Faraj, Hazem

AU - Kanjo, Wael

AU - Yasin, Ahmed

AU - Toba, Haneen

AU - Mohammed, Wafa

AU - Hamad, Mohammad Khair

AU - Al-Tikrety, Nawras

AU - Baraa Habib, Mhd

AU - Awaisu, Ahmed

AU - Mahfouz, Ahmed

AU - Alyafei, Sumaya

AU - Arabi, Abdul Rahman

AU - Patel, Ashfaq

AU - Al-Hijji, Mohammed

N1 - Publisher Copyright: 2025 Rahhal, Hamamyh, Chapra, Zaza, Najim, Hemadneh, Faraj, Kanjo, Yasin, Toba, Mohammed, Hamad, Al-Tikrety, Baraa Habib, Awaisu, Mahfouz, Alyafei, Arabi, Patel and Al-Hijji.

PY - 2025

Y1 - 2025

N2 - In the published article, there was an error in the Funding statement. The authors declared receiving no financial support for the research, authorship, or publication of this article. The correct Funding statement appears below.

AB - In the published article, there was an error in the Funding statement. The authors declared receiving no financial support for the research, authorship, or publication of this article. The correct Funding statement appears below.

UR - https://www.scopus.com/pages/publications/105000465308

UR - https://www.scopus.com/pages/publications/105000465308#tab=citedBy

U2 - 10.3389/fcvm.2025.1580343

DO - 10.3389/fcvm.2025.1580343

M3 - Comment/debate

C2 - 40109296

AN - SCOPUS:105000465308

SN - 2297-055X

VL - 12

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

M1 - 1580343

ER -

Rahhal A, Hamamyh T, Chapra A, Zaza KJ, Najim M, Hemadneh M et al. Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669). Frontiers in Cardiovascular Medicine. 2025;12:1580343. doi: 10.3389/fcvm.2025.1580343

Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure (Frontiers in Cardiovascular Medicine, (2024), 11, (1383669), 10.3389/fcvm.2024.1383669)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this